Impact of MALDI-TOF will be highly dependent on the clinician.
Centre Hospitalier Universitaire de Poitiers, France.
Guillaume
G
Béraud
Magali
M
Garcia
Frederic F
FF
Rahbari-Oskoui
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D015373:Bacterial Typing Techniques / Q000379:methods*; D006801:Humans; D010820:Physicians; D010818:Practice Patterns, Physicians'; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*
D000900:Anti-Bacterial Agents